Muscella Antonella, Greco Simona, Elia Maria Giovanna, Storelli Carlo, Marsigliante Santo
Laboratory of Cell Physiology, Dipartimento di Scienze e Tecnologie Biologiche e Ambientali, University of Lecce, Ecotekne, Lecce, Italy.
J Cell Physiol. 2003 Oct;197(1):61-8. doi: 10.1002/jcp.10336.
We examined the signalling pathways responsible for the Ang II induction of growth in MCF-7 human breast cancer cells. Ang II in MCF-7 cells induced: (a) the translocation from the cytosol to membrane and nucleus of atypical protein kinase C-zeta (PKC-zeta) but not of PKC-alpha, -delta, - epsilon and -eta; (b) the expression of c-fos mRNA and protein; (c) the phosphorylation of the extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). All these effects were due to the activation of the Ang II type I receptor (AT1) since they were blocked by the AT1 antagonist losartan. The Ang II-stimulated ERK1/2 phosphorylation was blocked by (a) high doses of staurosporine, inhibitor of PKC-zeta, and by a synthetic myristoylated peptide with sequences based on the endogenous PKC-zeta pseudosubstrate region (zeta-PS); (b) PD098059, a mitogen-activated protein kinase kinase inhibitor (MAPKK/MEK); and, moreover, (c) the inhibitors of phosphoinositide 3-kinases (PI3K), LY294002 and wortmannin, thus indicating that PI3K may act upstream of ERK1/2. The Ang II-evoked c-fos induction was blocked only by high doses of staurosporine and by zeta-PS whilst PD098059, LY294002 and wortmannin were ineffective, thus indicating that c-fos induction is not due to ERK1/2 activity. When the epidermal growth factor-receptor (EGFR) tyrosine kinase activity was inhibited by the use of its inhibitor AG1478, Ang II was still able to induce ERK1/2 phosphorylation and c-fos expression, therefore proving that the transactivation of EGFR was not required for these Ang II effects in MCF-7 cells. The previously reported proliferation of MCF-7 cells induced by Ang II was blocked by PD098059 and by wortmannin in a dose-dependent manner, thereby indicating that in MCF-7 cells the PI3K and ERK pathways mediate the mitogenic signalling of AT1. Our results suggest that in MCF-7 cells Ang II activates multiple signalling pathways involving PKC-zeta, PI3K and MAPK; of these pathways only PKC-zeta appears responsible for the induction of c-fos.
我们研究了负责血管紧张素II(Ang II)诱导MCF-7人乳腺癌细胞生长的信号通路。MCF-7细胞中的Ang II诱导:(a)非典型蛋白激酶C-ζ(PKC-ζ)从胞质溶胶转位至膜和细胞核,而PKC-α、-δ、-ε和-η未发生转位;(b)c-fos mRNA和蛋白的表达;(c)细胞外信号调节蛋白激酶1和2(ERK1/2)的磷酸化。所有这些效应均归因于血管紧张素II 1型受体(AT1)的激活,因为它们被AT1拮抗剂氯沙坦阻断。Ang II刺激的ERK1/2磷酸化被以下物质阻断:(a)高剂量的星形孢菌素,PKC-ζ的抑制剂,以及基于内源性PKC-ζ假底物区域序列的合成肉豆蔻酰化肽(ζ-PS);(b)PD098059,一种丝裂原活化蛋白激酶激酶抑制剂(MAPKK/MEK);此外,(c)磷酸肌醇3-激酶(PI3K)的抑制剂LY294002和渥曼青霉素,从而表明PI3K可能在ERK1/2的上游起作用。Ang II诱发的c-fos诱导仅被高剂量的星形孢菌素和ζ-PS阻断,而PD098059、LY294002和渥曼青霉素无效,从而表明c-fos诱导不是由于ERK1/2活性。当使用表皮生长因子受体(EGFR)酪氨酸激酶抑制剂AG1478抑制EGFR酪氨酸激酶活性时,Ang II仍能够诱导ERK1/2磷酸化和c-fos表达,因此证明在MCF-7细胞中这些Ang II效应不需要EGFR的反式激活。先前报道的Ang II诱导的MCF-7细胞增殖被PD098059和渥曼青霉素以剂量依赖性方式阻断,从而表明在MCF-7细胞中PI3K和ERK途径介导AT1的促有丝分裂信号传导。我们的结果表明,在MCF-7细胞中Ang II激活涉及PKC-ζ、PI3K和MAPK的多种信号通路;在这些通路中,只有PKC-ζ似乎负责c-fos的诱导。